DMW - Deutsche Medizinische Wochenschrift, Inhaltsverzeichnis Dtsch Med Wochenschr 2008; 133(24): 1306DOI: 10.1055/s-2008-1077259 Pro & Contra | CommentaryHypertensiologie© Georg Thieme Verlag KG Stuttgart · New YorkImpfung gegen Angiotensin II - proImmunization against angiotensin II - pro J. Nussberger1 1Département de médecine interne, CHUV, Lausanne Artikel empfehlen Abstract Artikel einzeln kaufen(opens in new window) Schlüsselwörter Hypertonie - Angiotensin II - Impfung Key words hypertension - angiotensin II - vaccination Volltext Referenzen Literatur 1 Ambühl P M. et al . A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens. 2007; 25 63-72 2 Brown M J. et al . Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects. Clin Sci. 2004; 107 167-173 3 MullerJE, Tofler G H, Stone P H. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989; 79 733-743 4 Tissot A C. et al . Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study. Lancet. 2008; 371 821-827 Prof. Dr. Jürg Nussberger CHUV-NES 6027, Department of Internal Medicine, Division of Angiology and Hypertension CH-1011 Lausanne Telefon: ++ 4121/3140-750 Fax: ++ 4121/3140-761 eMail: Juerg.Nussberger@chuv.ch